PRACTICE EXAM QUESTIONS
CURRENTLY TESTING REAL EXAM
QUESTIONS WITH VERIFIED
DETAILED ANSWERS (100% CORRECT
ANSWERS) /ALREADY GRADED A+
VERSION A
what are the risks of exposure to meds at diff points
in preg? - ....ANSWER...1st trimester: congenital
anomalies
2nd trimester: behavioral issues, learning
challenges, attention, cognitive issues
3rd: physiologic development (changes in body and
brain), effects on growth, effects on labor timing,
neonatal side effects
what is the idea of fetal programming? -
....ANSWER...-through mom's biochemistry, the fetus
"learns" what to expect regarding resources,
pathogens, etc and develops accordingly
,-experiences in the womb (maternal nutrition,
stress, etc) influence which genes are turned on or
off and therefore how brains and bodies develop
-severe, prolonged exposure to maternal distress
can make child's stress response system
hypersensitive and increase risk of preterm birth
what is relational ethics? - ....ANSWER...-the
principle that the wellbeing of mom and fetus are
intertwined rather than oppositional and both need
to be considered in treatment decisions
what are the top voiced concerns by patients
regarding meds in preg? - ....ANSWER...-miscarriage
-congenital malformation
-preterm delivery/low birth weight
-neonatal adaptation syndrome
-long term neurobehavioral effects
-autism
-persistent pulmonary hypertension of newborn
(baby doesnt get enough oxygen after birth)
risk of miscarriage/still birth with meds during preg?
- ....ANSWER...-not a true risk
,-risk is elevated for women who stopped SSRIs
prior to conception and for those who remained on
SSRIs in first trimester
-risk was due to underlying illness, not med
exposure
risk of PPHN (persistent pulmonary hypertension of
newborn (baby doesn't get enough oxygen after
birth))? - ....ANSWER...-very low risk
-other risk factors include prematurity, dom
violence, c-section delivery, smoking, NSAIDs,
obesity, black race, cardiac malformations, lung
abnormalities, untreated maternal dep
rates and symptoms of neonatal side
effects/neonatal adaptation syndrome -
....ANSWER...-happens in 10-30% of preg
-symptoms: jittery, irritability, feeding issues,
tremor, GI or sleep disturbances, high pitched cry,
quick breathing, increased muscle tone
-symptoms go away on their own, last less than 2
weeks and show up 0-48 hours after delivery
-breastfeeding might be protective
-no benefits to stopping SSRIs in 3rd trimester
, -baby usually discharged with mom
what is the risk of congenital anomalies ? -
....ANSWER...-not a true risk
-3% in general pop and SSRIs don't increase that
baseline risk
-no consistent fetal malformations or abnormalities
documented with any SSRIs
what is the risk of tabor timing; preterm birth/low
birth weight? - ....ANSWER...-slight increased risk
-same as continuous untreated dep; average is 5-7
days early
-risk is increased for lower weight but is the same
as for dep moms; less than 97g or 3.4 oz
what is the relationship between antidepressants
during pregnancy and behavioral/neural
developmental issues (autism/IQ)? - ....ANSWER...-
antidepressant dose and duration during pregnancy
doesn't predict cognitive or behavior outcome in kids
3-6 years
-not associated with increased risk of behavioral
probs in kids at 7years